Kenvue effort to dismiss Tylenol case rejected by Texas judge
Source: SeekingAlpha
2026-02-26 12:47:11 ET
More on Kenvue
- Kimberly-Clark: After The Kenvue Merger Vote, Ready To Rumble?
- Kimberly-Clark Just Proved Itself As Its Purchase Of Kenvue Nears (Upgrade)
- Kimberly-Clark And Kenvue Merger: Great Value Based On Combined Financials
- Quant check on Starboard Value's top Q4 holdings: QRVO, KVUE, AQN
- Kenvue Q4 2025 Earnings Preview
Read the full article on Seeking Alpha
For further details see:
Kenvue effort to dismiss Tylenol case rejected by Texas judge
Kenvue Inc.
NASDAQ: KVUE
KVUE Trading
-0.0% G/L:
$18.1897 Last:
10,532,887 Volume:
$18.19 Open:
KVUE Latest News
March 04, 2026 03:24:44 pm
Starboard Value Takes Stake in Fluor as Industrial Investment Cycles Reaccelerate
February 27, 2026 10:46:07 pm
Starboard Value LP Opens Major Stake in Clearwater Analytics' Investment Accounting Platform
February 18, 2026 05:29:29 pm
Stock Market Today, Feb. 18: Kenvue Rises After Earnings Beat Expectations
KVUE Stock Data
$35,097,495,754
1,883,616,694
N/A
492
N/A
Consumer Products - Healthcare
Consumer Staples
US
Summit
